Latest News about ARKG
Recent news which mentions ARKG
‘The short end of the curve is very sexy today’: But where should ETF investors bet on bonds?
February 09, 2023
From MarketWatch
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
February 07, 2023
From Motley Fool
From InvestorPlace
Eye DNA Synthesis Advances in Active Biotech ETF ARKG
February 01, 2023
Tickers
ARKG
From ETF Trends
Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company
January 31, 2023
From Benzinga
Why Teladoc Stock Popped 5% Today
January 27, 2023
From Motley Fool
From Benzinga
Active vs. passive? Why active ETFs face competition from ‘quasi-active’ smart beta funds in U.S. stock market
January 19, 2023
From MarketWatch
Get Benefits From Innovator ACCD in Health Tech ETF ARKG
January 18, 2023
Tickers
ARKG
From ETF Trends
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
January 11, 2023
From ETF Trends
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
January 11, 2023
From Benzinga
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
January 04, 2023
From Benzinga
War, Inflation, Fed Hawkishness, Elon Musk's Twitter Buy: How These Factors Weighed On Cathie Wood's Top Holdings In 2022
January 02, 2023
From Benzinga
Why Now Could Be Time to Buy No Cap Gain ARK Strats
December 30, 2022
From ETF Trends
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
December 29, 2022
From Motley Fool
'Study The Mindset Of Stonk Hodlers': This Fund Manager Rips Cathie Wood's Investment Strategy
December 22, 2022
From Benzinga
ARK Continues Contrarian Plays in ETFs TSLA, COIN, VERV
December 16, 2022
From ETF Trends
Gene Editing Stock in ARKG Gets Buy Rating
December 14, 2022
From ETF Trends
Why a Biotech ETF Might Cure Your Portfolio in 2023
December 07, 2022
From ETF Trends
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
December 07, 2022
From Benzinga
Why This Biotech Firm is the Top Weight in ARKG
November 28, 2022
From ETF Trends
From Benzinga
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
November 25, 2022
From Motley Fool
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
November 22, 2022
From Benzinga
ARK Completes Move to Florida With Broad Research Team
November 22, 2022
From ETF Trends
Cathie Wood Teams Up With This Investment Bank To Offer Ark Invest's ETFs In Canada
November 19, 2022
From Benzinga
ARK Partners With BMO to Bring ARK Funds to Canada
November 18, 2022
From ETF Trends
Biotech Earnings, Market Leap Boost ARKG Potential
November 11, 2022
From ETF Trends
5 Top Stocks Cathie Wood Is Buying This Week
November 04, 2022
From InvestorPlace
As Flu Season Consumers Prefer Telehealth, Watch ARKG
November 02, 2022
From ETF Trends
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
